This Phase 1 study tests the safety of OLX-07010, a drug designed to stop tau proteins from clumping in the brain—a hallmark of Alzheimer's disease. Researchers will give single or multiple doses to 88 healthy adults and elderly volunteers to see how the body handles the drug and…
Phase: PHASE1 • Sponsor: Oligomerix, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC